Earnings to watch: Boston Scientific (BSX) reports Q3 results tomorrow

What happened

Boston Scientific, a medical device company, reports third-quarter results Wednesday before the market opens. Last quarter revenue was $5.44 billion, up 7.5% from a year earlier, but next-quarter revenue guidance and full-year earnings-per-share guidance both missed analyst estimates.

Confirmed

Global impact / market context

Boston Scientific sells medical devices, so its sales trend shows whether hospitals are still spending on procedures and equipment. Analysts expect flat revenue this quarter, down from 20.3% growth a year earlier. A weak result could pressure the stock, while a beat could restore confidence.

Analyst inference

Two peers in healthcare equipment and supplies have already reported. Neogen grew revenue 6.5% and beat expectations by 7%, while Abbott Laboratories reported revenue up 14.5%, in line with expectations. These results give investors a rough benchmark for device demand this quarter.

Analyst inference

What to watch

1. Watch whether Boston Scientific meets the flat year-on-year revenue expectation, a sharp slowdown from the 20.3% growth recorded in the same quarter last year. Confirmed
2. Watch management's next-quarter and full-year guidance, since both missed estimates last quarter; another miss could weaken investor confidence in the company's outlook. Analyst inference
3. Compare Boston Scientific's revenue growth with Neogen's 6.5% and Abbott's 14.5%, to judge whether any shortfall reflects company-specific issues or broader device-market weakness. Proposed

Evidence

• stockstory.org